EACT Response to the European Bank Authority’s Consultation on the Treatment of CVA under SREP
Published: February 16, 2016
Paris - The EACT has responded to the European Banking Authority’s consultation on the treatment of CVA risk under the supervisory review and evaluation process (SREP).
The response highlights that the EBA’s mandate for issuing the proposed guidelines is questionable and that applying the guidelines would partially eliminate the exemption from CVA risk charge from which non-financial counterparties are benefitting under CRR.
Article Last Updated: November 26, 2020